Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved specifically for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, sleep apnea, or dyslipidemia
They can develop customized nutrition plans that help you feel full, learn portion control strategies, and create sustainable eating habits
Impact of obesity on atrial electrophysiological substrate
1GLP-1 medications like Ozempic and Wegovy may reduce alcohol cravings based on new clinical trial data 2A JAMA Psychiatry study found semaglutide reduced drinking quantity, cravings, and heavy drinking days 3GLP-1 drugs are NOT yet FDA-approved for treating alcohol use disorder 4Current FDA-approved alcohol addiction medications (naltrexone, acamprosate, disulfiram) are available and effective 5Medical detox with 24/7 supervision is the safest way to stop drinking If you've been following health news lately, you've likely heard about Ozempic and Wegovy, the blockbuster medications originally developed for diabetes and weight loss
There was an extreme drug shortage which triggered these rules that allowed compounded drugs to enter the market, and the compounded drugs were way more affordable, said Stacie Dusetzina, a professor of health policy and cancer research at Vanderbilt University School of Medicine
